Donepezil: Clinical Trials

56 trials of Donepezil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 9 unknown, 5 terminated, 2 withdrawn. 56 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 456Completed 39, Unknown 9, Terminated 5, Withdrawn 2, Not yet recruiting 1

Follow Donepezil: new trials by email Literature Review of Donepezil trials Research Report on Donepezil

Trials (filtered) newest first · largest first

All 56 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)
cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine) - Alzheimer Disease, Cholinesterase Inhibitors
Phase 4Not yet recruitingUniversity Hospital, Bordeaux12052024-06-012023-10-06
Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction
Donepezil, Placebo - Total Knee Arthroplasty, Fracture of Head of Femur Articular Displaced
Phase 4UnknownRenJi Hospital3602020-06-142020-12-29
Monitoring Anti-Dementia Drugs by Serum Levels
Donepezil, Memantine, Measurement of serum level of anti-dementia drug - Dementia, Dementia With Lewy Bodies
Phase 4CompletedZealand University Hospital1322020-02-042025-02-10
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
Tandospirone Citrate, Donepezil Hydrochloride - Alzheimer Disease, Cognitive Function
Phase 4UnknownZhejiang Provincial People's Hospital302017-05-202017-05-12
Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease
Donepezil, Placebos - Parkinson Disease
Phase 4UnknownKyung Hee University Hospital202017-04-112018-03-07
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
Donepezil - Alzheimer's Disease
Phase 4CompletedBeijing Friendship Hospital2412016-04-012024-08-23
A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
E2020, Placebo - Dementia, Lewy Body, Lewy Body Disease
Phase 4CompletedEisai Co., Ltd.1602015-03-012019-01-08
The Impact of Arousal Threshold in Obstructive Sleep Apnea
Donepezil, placebo - Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, San Diego442014-09-012019-08-08
Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
donepezil HCL, Placebo - Genetic Risk for Alzheimer's Disease
Phase 4CompletedThe Cleveland Clinic892014-05-012023-08-30
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
Donepezil HCL - Alzheimer's Disease
Phase 4CompletedEisai Korea Inc.1712014-02-012016-06-27
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
Donepezil - Alzheimer Disease, Mild Cognitive Impairment
Phase 4CompletedNew York State Psychiatric Institute1212013-10-012020-07-13
A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
Donepezil hydrochloride, Donepezil matching placebo - Dementia Associated With Cerebrovascular Disease
Phase 4CompletedEisai Co., Ltd.3022013-08-052020-01-10
Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
Ebixa, donepezil - Alzheimer's Disease, Dementia
Phase 4UnknownKonkuk University Medical Center1882013-01-012014-08-13
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Donepezil, Placebo - Neuropathic Pain
Phase 4TerminatedWake Forest University52012-12-012021-03-02
Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
Donepezil, Atropine - Mild Cognitive Impairment
Phase 4CompletedNew York State Psychiatric Institute412012-08-012018-07-09
Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial
Donepezil - Elderly, Delirium of Unknown (Axis III) Etiology
Phase 4TerminatedUniversity of Sao Paulo192012-08-012018-05-03
Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human The Effect of Donepezil on Perceptual Learning in Adult Amblyopia
Donepezil, Single-letter training, Uncrowd training - Amblyopia
Phase 4CompletedDennis Levi202012-05-012019-01-17
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
Donepezil, Placebo - Parkinson's Disease
Phase 4CompletedOregon Health and Science University212011-12-012021-10-05
Combination Treatment Study for Memory Impairment and Depression
Donepezil, Placebo, Citalopram - Depression, Mild Cognitive Impairment
Phase 4CompletedNew York State Psychiatric Institute862011-09-012017-10-17
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
Donepezil, placebo - Impaired Cognition, Schizophrenia
Phase 4UnknownCentral South University802011-06-012011-12-13

Showing 20 of 56. Sign in to see all of them.

Conditions studied

Alzheimer Disease (25)  ·  Cognitive Dysfunction (8)  ·  Dementia (8)  ·  Cognition Disorders (4)  ·  Delirium (3)  ·  Parkinson Disease (3)  ·  Sleep Apnea Syndromes (3)  ·  Sleep Apnea, Obstructive (3)  ·  Anosmia (2)  ·  Depression (2)  ·  Diabetic Neuropathies (2)  ·  Lewy Body Disease (2)  ·  Postoperative Complications (2)  ·  Schizophrenia (2)  ·  Stroke (2)

Sponsors

Eisai Inc. (7)  ·  Eisai Korea Inc. (4)  ·  Eisai Co., Ltd. (3)  ·  New York State Psychiatric Institute (3)  ·  Associacao Fundo de Incentivo a Psicofarmcologia (2)  ·  University of Pittsburgh (2)  ·  Wake Forest University (2)  ·  BeerYaakov Mental Health Center (1)  ·  Beijing Friendship Hospital (1)  ·  Central South University (1)  ·  Dennis Levi (1)  ·  Duke University (1)  ·  Duke-NUS Graduate Medical School (1)  ·  Ever Neuro Pharma GmbH (1)  ·  Gabinete Berthier y Martínez (1)

Countries

United States (26)  ·  South Korea (7)  ·  Brazil (3)  ·  China (3)  ·  Japan (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Philippines (1)  ·  Singapore (1)

Top investigators

Anita Murthy (2)  ·  Davangere Devanand, M.D. (2)  ·  Jihee Mun (2)  ·  Malaz Boustani, MD, MPH (2)  ·  Alistair Burns (1)  ·  Bruce G. Pollock, MD, PhD (1)  ·  Clive Holmes (1)  ·  Cuibai Wei, MD,PhD (1)  ·  Dalva Poyares, MD, PhD (1)  ·  Davangere Devanand, MD (1)  ·  Dennis M Levi, OD, PhD (1)  ·  Diansan Su (1)  ·  Dieter Meier, MD (1)  ·  Eric J. Lenze, MD (1)  ·  Gary W. Small, MD (1)

Results publications

PMID 16494088, PMID 17914039, PMID 18198262, PMID 18251622, PMID 18667813, PMID 18971479, PMID 19210951, PMID 19874395, PMID 19917989, PMID 22281004, PMID 23408503, PMID 24078735, PMID 24144505, PMID 24290367, PMID 24299497, PMID 24315979, PMID 25079803, PMID 26795874, PMID 27442715, PMID 28824369, PMID 29635383, PMID 30037778, PMID 30794310, PMID 31985467, PMID 32333591, PMID 33189083, PMID 34627332, PMID 40034344

NIH funding

R01NS057594 (2), 2017 (1), K23MH064196 (1), R01AG018487 (1), R01AG040093 (1), R01AG041795 (1), R01MH035182 (1), R01MH043832 (1), R21MH061801 (1)